DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Exelixis (NASDAQ: EXEL)

2.54 0.05 (2.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $2.54 2.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.49
Previous Close $2.49
Daily Range $2.47 - $2.55
52-Week Range $1.26 - $4.55
Market Cap $497.6M
P/E Ratio -1.80
Dividend (Yield) $0.00 (0.0%)
Volume 1,983,226
Average Daily Volume 4,527,291
Current FY EPS -$0.88




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary

Why Exelixis, Inc. Shares Skyrocketed 57% in February

Exelixis shares soared in February as shareholders await two key catalysts.

Is Exelixis (EXEL) Stock a Solid Choice Right Now? - Tale of the Tape

Exelixis (EXEL) Highlighted As Weak On High Volume

18 Biotech Stocks These Wall Street Analysts Are Tracking

Exelixis (EXEL) In A Perilous Reversal

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

XBI, FMI, EXEL, HALO: Large Inflows Detected at ETF

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2014 Results - Earnings Call Transcript

Exelixis (EXEL) Q4 2014 Results - Earnings Call Webcast

See More EXEL News...

EXEL's Top Competitors

EXEL $2.54 (2.01%)
Current stock: EXEL
TMO $133.69 (0.47%)
Current stock: TMO
ILMN $187.17 (1.52%)
Current stock: ILMN
WAT $124.11 (1.85%)
Current stock: WAT